Dr Kalra's commentary was intended to be a preliminary, personal response to the DEVOTE trial results as reported to the press. We apologise if it was not made sufficiently clear in the article that the results of the DEVOTE trial remain to be published in full, and have not yet therefore undergone scientific review.
In addition, Table 1 should include all the four arms of the ORIGIN trial: insulin glargine ? omega-3 polyunsaturated fatty acids; insulin glargine ? placebo; standard care ? omega-3 polyunsaturated fatty acids; and placebo comparator: standard care ? placebo.
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